Trial NCT04590781

View at ClinicalTrials.gov 
Org. Study IDs: XmAb18087-02
Secondary IDs: DUET 1-02

Last trial update was posted on 2023-04-20

MeSH Interventions

Pembrolizumab

MeSH Conditions

Carcinoma Carcinoma, Merkel Cell Lung Neoplasms Small Cell Lung Carcinoma

Other Conditions

Merkel Cell Carcinoma Small Cell Lung Cancer

Stopping Reasons

The study has been terminated early by the sponsor due to business decision.

Limitations And Caveats

Study was terminated by the sponsor and only 2 participants each were enrolled in Parts A and C. No participants were enrolled for Part B. Data were not collected for the prespecified analyses of efficacy, pharmacokinetics, and immunogenicity outcome measures.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID